G Medical Innovations Holdings Ltd (GMVD) Research
G Medical Innovations Holdings Ltd, along with its affiliated companies, operates as an early-stage commercial healthcare enterprise. It specializes in creating advanced mobile health and remote medical solutions for markets in the United States, China, and Israel. The company's product portfolio features Prizma, a user-friendly medical device that records vital signs, integrates with electronic medical records, and generates reports adhering to clinical standards. Another key offering is the Extended Holter Patch System, a multi-channel wearable biosensor designed for continuous electrocardiogram data collection for up to two weeks. Furthermore, it is developing a Wireless Vital Signs Monitoring System, intended for real-time and ongoing tracking of physiological parameters and biometrics. Beyond its devices, G Medical Innovations provides monitoring services, encompassing both independent diagnostic testing facility oversight and private patient monitoring. The company was established in 2014 and maintains its headquarters in Rehovot, Israel.
Market snapshot
- Symbol
- GMVD
- Price
- $0.18
- Day change
- +1.38%
- Market cap
- $1.8M
- 52-week range
- 0.145-13.825
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
Peer companies
Recent insider activity
- AWM Investment Company, Inc. — S-Sale (437500 shares) on 2023-03-31
- AWM Investment Company, Inc. — S-Sale (300000 shares) on 2023-04-03
- AWM Investment Company, Inc. — trade (0 shares) on 2023-03-31
Open G Medical Innovations Holdings Ltd (GMVD) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.